OMNIlife science, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From OMNIlife science, Inc.
Following its decision to maintain a stock listing for SillaJen earlier this month, the Korea Exchange has done the same for Kolon TissueGene, which had faced delisting but has resumed trading amid decisive moves to improve its business.
Plus deals with Synaffix/Emergence, Helsinn/Juniper and Sanyou/Shanghai KangaBio, while Takeda/Finch and Dong-A/Beactica ended prior collaborations.
Partnership with Mary Nhin, author of the “Ninja Life Hacks” children’s book series, will develop supplements and food for cognitive health in addition to other products “that promote a healthy emotional and physical relationship with foods.”
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in March and April 2017.
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- Apex Surgical, LLC.
- Enztec, Ltd.
- Orthopaedic Synergy, Inc.
- Praxim, S.A.
- The Corin Group